CVRx, Inc.

By person

27 insiders · 134 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GSK plc entity

10% owner

$4.95M (1)

—

+$4.95M

1,007,583

3.78%

$2.94M

+3,067%

Pardo Geoffrey B

Director

$4.95M (1)

—

+$4.95M

1,829,022

6.87%

$5.33M

—

NEA PARTNERS 10 L P entity

10% owner

$4.50M (2)

—

+$4.50M

2,199,471

8.26%

$6.41M

+158,821%

Jain Mudit K.

Director

$4.37M (10)

—

+$4.37M

1,927,936

7.24%

$5.62M

+106.6%

NEW ENTERPRISE ASSOCIATES 10 L P entity

10% owner

$4.06M (1)

—

+$4.06M

2,026,083

7.60%

$5.91M

—

Nielsen Kirk G.

Director

$2.71M (17)

—

+$2.71M

3,380,685

12.69%

$9.85M

+131.3%

JOHNSON & JOHNSON

10% owner

—

$733.14K (7)

−$733.14K

7,536,436

28.29%

$21.97M

+115.6%

NEHRA JOHN M

Director

$502.65K (3)

—

+$502.65K

28,366

0.1065%

$82.68K

+5,701%

Hykes Kevin

PRES & CEO

$274.97K (2)

$61.35K (1) scheduled

+$213.62K

284,237

1.07%

$828.47K

—

VERRASTRO PAUL

CHIEF MKTG & STRAT OFFICER

—

$171.52K (7) scheduled

−$171.52K

60,551

0.2273%

$176.49K

—

Binkowski Brent

CHIEF OPERATING OFFICER

$76.43K (1)

$3.34K (1) scheduled

+$73.09K

56,514

0.2121%

$164.72K

—

SLATTERY JOSEPH P

Director

$71.74K (3)

—

+$71.74K

39,365

0.1478%

$114.74K

—

John Robert Allen

Chief Revenue Officer

—

$31.33K (1) scheduled

−$31.33K

86,036

0.3229%

$250.77K

—

OASHEIM JARED

CHIEF FINANCIAL OFFICER

—

$13.78K (1) scheduled

−$13.78K

96,703

0.3630%

$281.86K

—

Adamson Philip B.

Chief Medical Officer

—

$9.97K (1) scheduled

−$9.97K

61,578

0.2311%

$179.48K

+3,247%

BRUHN-DING DEAN

VP OF REG. AFFAIRS AND QA

—

54,648

0.2051%

$159.28K

+867.6%

Morrison Gregory

CHIEF HUMAN RESOURCES OFFICER

—

34,000

0.1276%

$99.10K

—

BRINTNALL JOHN

CHIEF STRATEGY OFFICER AND SEC

—

31,527

0.1183%

$91.89K

+227.5%

DALE MICHAEL D

Director

—

29,005

0.1089%

$84.54K

—

Yared Nadim

CHIEF EXECUTIVE OFFICER

—

26,255

0.0985%

$76.53K

—

SHADAN MARTHA

Director

—

8,720

0.0327%

$25.42K

—

Hill, Mitch C.

Director

—

8,720

0.0327%

$25.42K

—

Ballinger Kevin J.

Director

—

8,720

0.0327%

$25.42K

—

Palmer Craig E.

SVP, U.S. SALES

—

1,229

0.0046%

$3.58K

—

Galle Liz

VP OF GLOBAL CLINICAL RESEARCH

—

778

0.0029%

$2.27K

—

Behbahani Ali

Director

—

316

0.0012%

$921.05

—

Johnson & Johnson Innovation - JJDC, Inc. entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

JOHNSON & JOHNSON

26 Nov 2025

10% owner

Sell indirect

6,337

$10.03

$63.56K

JOHNSON & JOHNSON

24 Nov 2025

10% owner

Sell indirect

2,200

$10.06

$22.13K

JOHNSON & JOHNSON

21 Nov 2025

10% owner

Sell indirect

500

$10.00

$5.00K

JOHNSON & JOHNSON

12 Nov 2025

10% owner

Sell indirect

1,000

$10.00

$10.00K

JOHNSON & JOHNSON

7 Nov 2025

10% owner

Sell indirect

200

$10.00

$2.00K

JOHNSON & JOHNSON

6 Nov 2025

10% owner

Sell indirect

52,332

$10.21

$534.31K

VERRASTRO PAUL

3 Aug 2023

CHIEF MKTG & STRAT OFFICER

Sell

628

$18.55

$11.65K

Show all 134 transactions →

By person

Individual transactions

What was left out